Drawing for CEMAND

USPTO serial 78103081

CEMAND

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
THOMAS, AMY E
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CEMAND?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jennet S. Walker

JENNET S WALKER PFIZER INC150 E 42ND STNEW YORK, NY 10017UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological, bacterial, viral and fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, tissue and skin repair preparations, dermatological preparations, and gynecological preparationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 10, 2002ABN1ABANDONMENT - EXPRESS MAILED—
May 28, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 13, 2002CNSLLETTER OF SUSPENSION MAILED—
May 2, 2002DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance